DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tazorac (Tazarotene Cutaneous) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

In human dermal safety studies, tazarotene 0.05% and 0.1% gels did not induce allergic contact sensitization, phototoxicity or photoallergy.

Psoriasis:

The most frequent adverse events reported with TAZORAC® Gel 0.05% and 0.1% were limited to the skin. Those occurring in 10 to 30% of patients, in descending order, included pruritus, burning/stinging, erythema, worsening of psoriasis, irritation, and skin pain. Events occurring in 1 to 10% of patients included rash, desquamation, irritant contact dermatitis, skin inflammation, fissuring, bleeding and dry skin. Increases in “psoriasis worsening” and “sun-induced erythema” were noted in some patients over the 4th to 12th months as compared to the first three months of a 1 year study. In general, the incidence of adverse events with TAZORAC® Gel 0.05% was 2 to 5% lower than that seen with TAZORAC® Gel 0.1%.

Acne:

The most frequent adverse events reported with TAZORAC® Gel 0.1% in the treatment of acne occurring in 10 to 30% of patients, in descending order, included desquamation, burning/stinging, dry skin, erythema and pruritus. Events occurring in 1 to 10% of patients included irritation, skin pain, fissuring, localized edema and skin discoloration.



REPORTS OF SUSPECTED TAZORAC SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Tazorac. The information is not vetted and should not be considered as verified clinical evidence.

Possible Tazorac side effects / adverse reactions in male

Reported by a consumer/non-health professional from United States on 2011-10-04

Patient: male weighing 3.2 kg (7.0 pounds)

Reactions: Maternal Exposure During Pregnancy, Pregnancy

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Tazorac



Possible Tazorac side effects / adverse reactions in 54 year old male

Reported by a physician from United States on 2012-02-15

Patient: 54 year old male weighing 142.7 kg (313.9 pounds)

Reactions: Prostate Cancer

Suspect drug(s):
Tazorac

Other drugs received by patient: Neurontin



Possible Tazorac side effects / adverse reactions in 42 year old female

Reported by a consumer/non-health professional from United States on 2012-02-17

Patient: 42 year old female

Reactions: Application Site Discolouration

Suspect drug(s):
Tazorac



See index of all Tazorac side effect reports >>

Drug label data at the top of this Page last updated: 2010-10-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017